AstraZenica $AZN drug Tagrisso cut risk of lung cancer death or relapse by four-fifths over three 3yrs, according to detailed results from a study that raises survival prospects for patients in early stages
#investment #investing #stocks #bonds #economy 

https://t.co/rjNA9wwKGX